Details for New Drug Application (NDA): 016814
✉ Email this page to a colleague
NDA 016814 describes NORISODRINE AEROTROL, which is a drug marketed by Abbott and is included in one NDA. Additional details are available on the NORISODRINE AEROTROL profile page.
The generic ingredient in NORISODRINE AEROTROL is isoproterenol hydrochloride. There are seventeen drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the isoproterenol hydrochloride profile page.
The generic ingredient in NORISODRINE AEROTROL is isoproterenol hydrochloride. There are seventeen drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the isoproterenol hydrochloride profile page.
Summary for 016814
| Tradename: | NORISODRINE AEROTROL |
| Applicant: | Abbott |
| Ingredient: | isoproterenol hydrochloride |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | DISC;INHALATION | Strength | 0.25% | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
